Last month's approval of the advanced generation ventricular assist device (VAD) from Thoratec (Pleasanton, California) — the HeartMate II Left Ventricular Assist System (LVAS) — is leading the way in heart pump devices that are smaller, and touted as more efficient, and thus more available for implantation in smaller bodies: women, smaller men and younger people.